Company intelligence / Profile preview

CannPal Animal Therapeutics

New South Wales* or Western Australia* (*see note), Australiacannpal.com ↗

Ownership: Private
Development stage: Phase 2

Overview

CannPal developed cannabinoid-based therapeutics for companion animals with a focus on safety and efficacy. Their lead programs targeted pain/inflammation and skin health using plant-derived cannabinoids such as CBD and THC. The company advanced several products through preclinical/early clinical stages, with at least one nutraceutical supplement reaching commercialization in the US market via online retail channels as of mid-2020. They also entered into exclusive licensing agreements to use proprietary drug delivery technologies like MicroMAX® from CSIRO to enhance product efficacy.

Therapeutic areas: PsychiatryDermatologyImmunologyNeurology
Modalities: Small molecules (cannabinoids, including CBD and THC)Plant-derived compounds
Industry: Veterinary

Drug pipeline

2 assets

CPAT-01

Phase 2

Indications: Pain, Inflammation, Osteoarthritis

1 more asset in the full pipeline.

Request access →

Partnerships

Commonwealth Scientific and Industrial Research Organisation (CSIRO) – research collaboration/licensing agreement for MicroMAX® technology.

Beyond the preview

Go deeper on CannPal Animal Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CannPal Animal Therapeutics.

Explore the full profile